Maruti Suzuki Starts Production at ₹3,900 Cr Gujarat Plant; Total Capacity Hits 2.9M Units
Maruti Suzuki has operationalized its fourth manufacturing line at the Hansalpur facility in Gujarat, adding 250,000 units of annual capacity. This milestone elevates the site's total output to 1 million units, making it the first Suzuki location globally to reach this scale.
NLC India Subsidiary Bags 900 MW Solar Project From GUVNL via Competitive Bidding
NLC India Renewables Limited (NIRL), a wholly-owned subsidiary of NLC India, has secured a Letter of Intent for a 900 MW solar power project from Gujarat Urja Vikas Nigam Limited. The project was won through a competitive bidding process and marks a significant expansion of the company's green energy portfolio.
Euro Pratik Sales to Launch New Pastelite and Prism Design Collections in August 2026
Euro Pratik Sales Limited has announced the upcoming launch of two new decorative product collections, Pastelite Volume 2 and Prism, scheduled for August 2026. This expansion aims to capitalize on the previous success of the Pastelite range while introducing new premium surfaces for the high-end interior design market.
MTAR Technologies Secures ₹819.94 Crore Incremental Order for Aerospace Projects
MTAR Technologies Limited has announced a significant amendment to a previously received purchase order, increasing its total value to USD 324.62 million. This revision provides an incremental order inflow of approximately ₹819.94 crore, substantially strengthening the firm's long-term revenue visibility.
MTAR Technologies Q1 FY27 PAT Rises 364% to ₹50.2 Cr; Order Book Hits ₹5143 Cr
MTAR Technologies reported a significant surge in its financial performance for Q1 FY27, with consolidated revenue growing by 130.4% YoY. The company achieved a record order book of ₹5,143.3 Cr, driven by major wins in the civil nuclear and clean energy sectors.
HFCL Q1FY27 Revenue Surges 119% to ₹1,914.98 Cr as Order Book Hits Record ₹26,665 Cr
HFCL Limited delivered a record-breaking performance in Q1FY27, reporting a 119.85% year-on-year revenue increase and a significant expansion in EBITDA margins to 23.25%. The company has upwardly revised its annual growth guidance based on a massive order book of ₹26,665 crore and rising global demand for optical connectivity and defense technologies.
Sakar Healthcare Q1 Results: Net Profit Surges 120% as Oncology Pivot Gains Momentum
Sakar Healthcare delivered a robust performance in Q1 FY27, marked by a 120% jump in net profit and a significant expansion of its specialized oncology segment. The company is successfully transitioning toward a vertically integrated, export-led oncology model with improving operational margins.
SBI Raises ₹4,691 Crore via Basel III Compliant Additional Tier 1 Bonds at 7.75%
State Bank of India has successfully raised ₹4,691 crore through the issuance of Basel III compliant Additional Tier 1 (AT1) bonds. The offering, which marks the bank's first such issuance for the current financial year, was oversubscribed more than twofold, reflecting strong institutional demand for the lender's debt instruments.
Gland Pharma Launches USFDA Approved Sugammadex Injection in 1.6 Billion Dollar US Market
Gland Pharma Limited has secured USFDA approval and executed the market launch of Sugammadex Injection in the United States. This generic alternative to Bridion targets a substantial perioperative therapy segment that recorded $1.6 billion in annual sales through April 2026.